| NDC Code | 0093-3044-05 |
|---|
| Package Description | 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0093-3044-05) |
|---|
| Product NDC | 0093-3044 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Verapamil Hydrochloride |
|---|
| Non-Proprietary Name | Verapamil Hydrochloride |
|---|
| Dosage Form | TABLET, FILM COATED, EXTENDED RELEASE |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20140129 |
|---|
| End Marketing Date | 20200131 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA074587 |
|---|
| Manufacturer | Teva Pharmaceuticals USA Inc |
|---|
| Substance Name | VERAPAMIL HYDROCHLORIDE |
|---|
| Strength | 180 |
|---|
| Strength Unit | mg/1 |
|---|
| Pharmacy Classes | P-Glycoprotein Inhibitors [MoA],Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA] |
|---|